About The Valve Wire
Our Mission
The Valve Wire provides balanced, expert-skeptical coverage of structural heart disease — transcatheter AND surgical approaches to aortic, mitral, and tricuspid valves. We aggregate research from peer-reviewed journals, regulatory filings, clinical trial registries, financial data, and the field’s social conversations, then synthesize them into a daily digest and a weekly podcast.
Our audience: cardiac surgeons, interventional cardiologists, trainees, informed patients, industry stakeholders, and regulators. Whether you are in the cath lab, the operating room, the boardroom, or the waiting room — The Valve Wire keeps you current on the field.
Editorial Stance
Many structural heart technologies have run ahead of the science and the guidelines. We commit to balanced, circumspect analysis:
- •We always present competing perspectives for and against favorable findings
- •We flag study limitations: non-randomized designs, industry sponsorship, short follow-up, small samples
- •When reporting favorable transcatheter outcomes, we note durability concerns, patient selection bias, and surgical alternatives
- •Our tone is expert skepticism — enthusiastic about real advances, always questioning
- •We reference critical perspectives from named field leaders (Badhwar, Mehaffey, Kaul, Miller, Chikwe, and others)
Methodology
The Valve Wire’s daily digest aggregates from: PubMed and NCBI, bioRxiv and medRxiv preprints, 12 specialty journal RSS feeds, Google News, FDA regulatory announcements, ClinicalTrials.gov, SEC EDGAR filings, market data, and curated social channels. A knowledge base of 52 indexed landmark studies and the full text of the ACC/AHA 2020 + ESC 2025 valve guidelines is loaded into every editorial synthesis.
Every published claim flagged with a specific number, p-value, or trial attribution is verified against source material. Editorial judgment remains with a human editor on every weekly podcast.
AI Disclosure
The Valve Wire is AI-assisted, not AI-replaced. Source aggregation, summarization, and first-pass synthesis are performed by Claude (Anthropic), with editorial direction and final review by E. Nolan Beckett, MD. The weekly podcast script is reviewed and revised before publication. While we strive for accuracy, AI-synthesized content should not be considered medical advice — always consult primary sources and clinical guidelines for patient care decisions.
Editor
E. Nolan Beckett, MD is a practicing physician focused on adult structural heart disease — transcatheter and surgical approaches to aortic, mitral, and tricuspid valve replacement and repair.
The Valve Wire takes no industry funding, runs no sponsored content, and accepts no advertising. The editorial moat — clinical training applied to the day’s evidence, with explicit skepticism of both device-industry triumphalism and surgical defensiveness — is the publication’s only asset.
Contact
Questions, corrections, or feedback? Reach the editor at nolan.beckett@pm.me.